|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 01, 2017 ) According to Publisher, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 growing at a CAGR of 14.3%. In present scenario people are exposed to various harmful conditions which are affecting them through cancer and immunotherapy drugs are helping the people out. Rising cancer therapies coupled with lesser side effects are the factors provoking the market demand. Moreover high prevalence of lifestyle diseases are sustaining the market growth. However, high cost of therapy drugs is major factor restraining the market.
For more information about this report: http://www.reportsweb.com/immunotherapy-drugs-global-market-outlook-2016-2022
Monoclonal antibodies is accounted for largest market share while Checkpoint inhibitors is estimated to be the fastest growing segment on account of its less effect to normal cells compared to ordinary therapeutics. North America commanded the largest market share followed by Europe owing to large government funding in cancer techniques and R&D. Quick drug approvals is also a major factor helping the regional growth.
Some of the key players of the Immunotherapy Drugs market include Aduro BioTech Inc, Agenus Inc, Amgen Inc., Bavarian Nordic A/S, Bellicum Pharmaceuticals Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Celgene Corporation, DenDrit Biotech USA, ELI Lilly and Company, F. Hoffmann-La Roche Ag, Galena Biopharma Inc, Genentech Inc, Glaxosmithkline Plc, Merck & Co., Inc., NewLink Genetics Corp., Novartis International Ag, Oxford BioTherapeutics Ltd., Seattle Genetics, Inc. and Spectrum Pharmaceuticals, Inc..
Drug Types Covered:
- Checkpoint Inhibitors
- Interferons
- Interleukins
- Monoclonal Antibodies
- Vaccines
Applications Covered:
- Blood Cancer
- Breast Cancer
- Cervical Cancer
- Gastric Cancer
- Glioblastoma
- Lung Cancer
- Melanoma
- Prostate Cancer
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001564893/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
9.1 Aduro BioTech Inc
9.2 Agenus Inc
9.3 Amgen Inc.
9.4 Bavarian Nordic A/S
9.5 Bellicum Pharmaceuticals Inc
9.6 Biogen Idec Inc
9.7 Bristol-Myers Squibb Company
9.8 Celgene Corporation
9.9 DenDrit Biotech USA
9.10 ELI Lilly and Company
9.11 F. Hoffmann-La Roche Ag
9.12 Galena Biopharma Inc
9.13 Genentech Inc
9.14 Glaxosmithkline Plc
9.15 Merck & Co., Inc.
9.16 NewLink Genetics Corp.
9.17 Novartis International Ag
9.18 Oxford BioTherapeutics Ltd.
9.19 Seattle Genetics, Inc.
9.20 Spectrum Pharmaceuticals, Inc.
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001564893/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
